TENAYA THERAPEUTICS, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • July 9th, 2021 • Tenaya Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
This Indemnification Agreement (this “Agreement”) is dated as of [insert date], and is between Tenaya Therapeutics, Inc., a Delaware corporation (the “Company”), and [insert name of indemnitee] (“Indemnitee”).
June 25, 2021 Timothy Hoey c/o Tenaya Therapeutics, Inc. Re: Confirmatory Employment Letter Dear Tim:Employment Letter Agreement • July 9th, 2021 • Tenaya Therapeutics, Inc. • Biological products, (no disgnostic substances) • Colorado
This confirmatory employment letter agreement (the “Agreement”) is entered into between you and Tenaya Therapeutics, Inc. (the “Company” or “we”), effective as of the effective date of the Company’s registration statement relating to the Company’s initial public offering (the “Effective Date”), to confirm the terms and conditions of your employment with the Company as of the Effective Date.
SUMMARY OF BASIC LEASE INFORMATIONLease • July 9th, 2021 • Tenaya Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
INDUSTRIAL LEASE – MULTI-TENANT by and between TERRENO PARK UNION CITY LLC and TENAYA THERAPEUTICS, INC. Dated: February 12, 2021Industrial Lease • July 9th, 2021 • Tenaya Therapeutics, Inc. • Biological products, (no disgnostic substances)
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. LICENSE AGREEMENTLicense Agreement • July 9th, 2021 • Tenaya Therapeutics, Inc. • Biological products, (no disgnostic substances) • Texas
This License Agreement (this “Agreement”) is dated as of January 10, 2020 (the “Effective Date”) by and between The Board of Regents (“Board”) of the University of Texas System (“System”), an agency of the State of Texas, on behalf of The University of Texas Southwestern Medical Center (“UT Southwestern”), a component institution of System (“Licensor”), and Tenaya Therapeutics, Inc., a Delaware corporation (“Licensee”). Licensor and Licensee may be referred to herein as a “Party” or, collectively, as “Parties”.
TENAYA THERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT December 17, 2020Investors’ Rights Agreement • July 9th, 2021 • Tenaya Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
This Amended and Restated Investors’ Rights Agreement (this “Agreement”) is dated as of December 17, 2020, and is between Tenaya Therapeutics, Inc., a Delaware corporation (the “Company”), and the persons and entities listed on Exhibit A (each, an “Investor” and collectively, the “Investors”).
Leone Patterson June 18, 2021 Dear Leone:Tenaya Therapeutics, Inc. • July 9th, 2021 • Biological products, (no disgnostic substances)
On behalf of Tenaya Therapeutics, Inc. (“we” or the “Company”), I am pleased to invite you to join the Company on the terms and conditions set forth in this letter agreement (the “Agreement”), effective as of the date on which you commence employment with the Company (the “Effective Date”). We look forward to the possibility of your joining our Company.
